E-Newsletter - July 2022
Alliance Foundation Awards
ALLIANCE FOUNDATION FUNDS RESEARCH ADDRESSING HIGH-PRIORITY AREAS
The Alliance for Clinical Trials in Oncology Foundation offers support for research focused on addressing high-priority research areas defined during the Alliance Scientific Strategic Retreat, which is held every two years. The goal of these priorities is to focus innovation by Alliance scientific committees on a few strategic areas, with the expectation that attention to these priorities will challenge researchers to move beyond what is currently possible and accelerate the development of new treatments, cancer control approaches, and cancer care delivery results. These strategic priorities generally focus upon fostering engagement of new disciplines or technologies relevant to Alliance research, or upon work to improve the design and implementation of Alliance clinical trials.
The following include five proposals selected for funding this cycle by the Alliance Foundation.
For more information about current Alliance strategic priorities or the Alliance Foundation Special Projects Allocation, click here.
For other articles in this issue of the Alliance E-news Newsletter, see below:
-
Nursing in the Modern Clinical Trials Era
Lisa A. Kottschade, MSN, APRN, CNP - Chair, Alliance Oncology Nursing Committee -
July is National Sacroma and Bone Cancer Awareness Month
A091902: Angiosarcoma -
Spotlight on Alliance Trials
*Recently Activated Trials
A221803 (Reducing Radiation Dermatitis - Breast Cancer
A091903 (Resected Mucosal Melanoma)
*Ongoing Trials
A011801 (COMPASS HER2 RD/Breast Cancer)
A021602 (CABINET/Advanced Neuroendocrine Tumors)
A021804 (Advanced Pheochromocytoma and Paraganglioma)
A031902 (CASPAR/Metastatic Castration-resistant Prostate Cancer)
A071702 (Somatically Hypermutated Recurrent Glioblastoma)
A081801 (Non-small Cell Lung Cancer) -
Announcements
Call for Nominations: Charles G. Moertel Lecture 2023
2022 Alliance for Clinical Trials in Oncology Foundation Special Projects Allocation Awards
Alliance Myeloma Committee Chair Appointment
Alliance Board of Directors Approve New Program for Procedure-Based Therapy (PPBT)
New Alliance Participant Engagement Portal to Launch Soon -
Alliance in the News
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention - Alliance NCTN/NCORP/AFT at 2022 ASCO